The requirement for and changing composition of the activating protein-1 transcription factor during differentiation of human leukemia HL60 cells induced by 1,25-dihydroxyvitamin D3.
about
Isoforms of p38MAPK gamma and delta contribute to differentiation of human AML cells induced by 1,25-dihydroxyvitamin D₃The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia TherapyVitamin D and differentiation in cancer.Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemiaSilibinin can induce differentiation as well as enhance vitamin D3-induced differentiation of human AML cells ex vivo and regulates the levels of differentiation-related transcription factors.Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment.The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2CERK5 pathway regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells.Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistanceExpression of human kinase suppressor of Ras 2 (hKSR-2) gene in HL60 leukemia cells is directly upregulated by 1,25-dihydroxyvitamin D(3) and is required for optimal cell differentiationBoth IKKalpha and IKKbeta are implicated in the arsenite-induced AP-1 transactivation correlating with cell apoptosis through NF-kappaB activity-independent manner.c-Jun N-terminal kinase 2 (JNK2) antagonizes the signaling of differentiation by JNK1 in human myeloid leukemia cells resistant to vitamin DVitamin D Control of Hematopoietic Cell Differentiation and Leukemia.Differentiation-inducing potency of the seco-steroid JK-1624F2-2 can be increased by combination with an antioxidant and a p38MAPK inhibitor which upregulates the JNK pathway.
P2860
Q24569633-CEF66B59-D302-4209-B970-7B395A82BBCCQ26799596-75465427-EC02-4517-8E78-23B50EAFB930Q33646179-DA3061BB-436B-4107-84C0-1799350F4FE1Q33680919-3EA196C8-8C72-4600-8CD9-BD29CB16A165Q33927891-0C8FD883-FC9C-4C25-8AE2-39B89458AE7FQ34545434-26453E32-4D36-40FB-B8FE-567CAEEA1B13Q34616532-442A6875-BE6E-4F3D-B860-E53EA7A0716DQ35181504-6B7B9FDB-C98E-4CFA-9FA8-D70B8AA16FAAQ35189239-BC64CA5C-38AA-464B-944D-13A82FC7AFAFQ35954885-818CEC36-9B7D-48E7-9B00-E642DBA2CB4CQ35958335-F499B03D-3882-49E5-8FDA-BC93A35D0771Q36983249-5F3471DD-25FD-4782-A6D8-2D897CD93ED2Q37252079-BF7435D0-520A-4E7F-98D4-3C2276B34C99Q39037456-721A35C5-9715-4544-B5A1-C9ACD6835BE5Q40116924-913DFCDD-A87D-47D6-853A-B5CD9C27F8A5
P2860
The requirement for and changing composition of the activating protein-1 transcription factor during differentiation of human leukemia HL60 cells induced by 1,25-dihydroxyvitamin D3.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The requirement for and changi ...... d by 1,25-dihydroxyvitamin D3.
@en
The requirement for and changi ...... d by 1,25-dihydroxyvitamin D3.
@nl
type
label
The requirement for and changi ...... d by 1,25-dihydroxyvitamin D3.
@en
The requirement for and changi ...... d by 1,25-dihydroxyvitamin D3.
@nl
prefLabel
The requirement for and changi ...... d by 1,25-dihydroxyvitamin D3.
@en
The requirement for and changi ...... d by 1,25-dihydroxyvitamin D3.
@nl
P2860
P1433
P1476
The requirement for and changi ...... d by 1,25-dihydroxyvitamin D3.
@en
P2093
George P Studzinski
Xuening Wang
P2860
P304
P356
10.1158/0008-5472.CAN-05-3109
P407
P577
2006-04-01T00:00:00Z